Isaac Meilijson

This study models the affinity maturation process to assess the roles of proliferation and mutation in the humoral immune response, finding that multiple strategies can yield optimal outcomes.

ENLIGHT predicts patient response to targeted and immunotherapies using tumor transcriptomes without prior treatment response data, showing better accuracy than existing transcriptomics-based signatures.

The authors withdrew their manuscript due to mathematical issues in their analysis approach after correcting brain size adjustments.

This study compares proliferation and migration transcriptomic signatures in breast cancer, finding migration is more strongly linked to patient survival.